Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Robert F. Kennedy Jr. petitioned the FDA to revoke authorization of the shots when they were in high demand and thousands of ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Rare instances of vaccine side-effects must not be used to “undermine the vital public health role that vaccination plays in ...